Profile
Corporate information
Official name
PharmAbcine Incorporated
Registration country
Official name
PharmAbcine Incorporated
Registration country
Investment activity status
Active investor
Company type
Develops fully human therapeutic monoclonal antibody (mAb)Funding
Funding rounds
(1 Sep 2009)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Novartis Services Inc |
+1 (617) 871-3536 |
N/A | |
Novartis Venture Funds The corporate venturing arm of Novartis. |
+41 (61) 324-6210 |
Series A | |
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
N/A | |
Tong Yang Venture Capital Corp |
+1 (650) 233-9834 |
Series A |